Cargando…

Sphingomyelin Liposomes Containing Soluble Leishmania major antigens Induced Strong Th2 Immune Response in BALB/c Mice

Objective(s): Soluble Leishmania antigens (SLA) provide suitable protection against leishmaniasis in murine model when delivered by an appropriate delivery system. Liposomes have been shown to be suitable vaccine delivery systems against leishmaniasis, however, the phospholipase-A (PLA) activity of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chavoshian, Omid, Biari, Nazanin, Badiee, Ali, Khamesipour, Ali, Abbasi, Azam, Saberi, Zahra, Jalali, Seyed Amir, Jaafari, Mahmoud Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804844/ https://www.ncbi.nlm.nih.gov/pubmed/24171074

Ejemplares similares

Sphingomyelin liposome bearing whole Leishmania lysate antigens induce strong Th2 immune response in BALB/c mice
por: Biari, Nazanin, et al.
Publicado: (2021)

Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model
por: Golali, Ensieh, et al.
Publicado: (2012)

Evaluation of Immune Response against Leishmaniasis in BALB/c Mice Immunized with Cationic DOTAP/DOPE/CHOL Liposomes Containing Soluble Leishmania major Antigens
por: HOJATIZADE, Mansure, et al.
Publicado: (2019)

The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice
por: Hejazi, H, et al.
Publicado: (2010)

The role of ISCOMATRIX bilayer composition to induce a cell mediated immunity and protection against leishmaniasis in BALB/c mice
por: Mehravaran, Ahmad, et al.
Publicado: (2016)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Degradation of Host Sphingomyelin Is Essential for Leishmania Virulence
por: Zhang, Ou, et al.
Publicado: (2009)

Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice
por: Calvo, Alba, et al.
Publicado: (2020)

Immunization Against Cutaneous Leishmaniasis by Alginate Microspheres Loaded With Autoclaved Leishmania Major (ALM) and Quillaja Saponins
por: Tafaghodi, Mohsen, et al.
Publicado: (2016)

Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects
por: Shariat, Sheida, et al.
Publicado: (2015)

The role of nanoliposome bilayer composition containing soluble leishmania antigen on maturation and activation of dendritic cells
por: Saremi, Sara Shokooh, et al.
Publicado: (2018)

Sphingomyelin Liposomes Containing Porphyrin-phospholipid for Irinotecan Chemophototherapy
por: Carter, Kevin A, et al.
Publicado: (2016)

The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB/c mice946
por: Rahimi, Sara, et al.
Publicado: (2023)

Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
por: Tahaghoghi-Hajghorbani, Sahar, et al.
Publicado: (2023)

Insights from the analysis of a predicted model of gp63 in Leishmania donovani
por: Razzazan, Ali, et al.
Publicado: (2008)

Therapy with Sodium Stibogluconate in Stearylamine-Bearing Liposomes Confers Cure against SSG-Resistant Leishmania donovani in BALB/c Mice
por: Roychoudhury, Jayeeta, et al.
Publicado: (2011)

Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer
por: Naghibi, Laleh, et al.
Publicado: (2020)

Optimization of a Method to Prepare Liposomes Containing HER2/Neu- Derived Peptide as a Vaccine Delivery System for Breast Cancer
por: Shariat, Sheyda, et al.
Publicado: (2014)

Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica: study protocol for a randomized, controlled trial
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2021)

Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy
por: Yazdani, Mona, et al.
Publicado: (2021)

Leishmania mexicana Gp63 cDNA Using Gene Gun Induced Higher Immunity to L. mexicana Infection Compared to Soluble Leishmania Antigen in BALB/C
por: Rezvan, H, et al.
Publicado: (2011)

Treatment of Cutaneous Lesion of 20 Years’ Duration Caused by Leishmanization
por: Khamesipour, Ali, et al.
Publicado: (2012)

Improvement of the Solubility Amphotericin B Using Olive Oil Nanoemulsion Coated with Chitosan for More Effective Treatment of Zoonotic Cutaneous Leishmaniasis
por: Taghizadeh, Elnaz, et al.
Publicado: (2021)

Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy
por: Mirhadi, Elaheh, et al.
Publicado: (2022)

Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice
por: Danesh-Bahreini, Mohammad Ali, et al.
Publicado: (2011)

Antigenic profile of heat-killed versus thimerosal-treated Leishmania major using sodium dodecyl sulfate-polyacrylamide gel electrophoresis
por: Arjmand, Reza, et al.
Publicado: (2015)

The Route of Leishmania tropica Infection Determines Disease Outcome and Protection against Leishmania major in BALB/c Mice
por: Mahmoudzadeh-Niknam, Hamid, et al.
Publicado: (2013)

Antileishmanial Activity of Liposomal Clarithromycin against Leishmania Major Promastigotes
por: Sazgarnia, Ameneh, et al.
Publicado: (2012)

P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER)
por: SOLEIMANIFARD, Simindokht, et al.
Publicado: (2014)

Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial
por: ESKANDARI, Seyed Ebrahim, et al.
Publicado: (2019)

Immunization against Leishmania major infection in BALB/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens
por: Salehi-Sangani, Ghodratollah, et al.
Publicado: (2019)

ON THE COMPONENTS OF SPHINGOMYELIN
por: Levene, P. A.
Publicado: (1913)

Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy
por: Askarizadeh, Anis, et al.
Publicado: (2023)

Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2018)

Raft-based sphingomyelin interactions revealed by new fluorescent sphingomyelin analogs
por: Kinoshita, Masanao, et al.
Publicado: (2017)

Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
por: Webb, M. S., et al.
Publicado: (1995)

Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice
por: Borborema, Samanta Etel Treiger, et al.
Publicado: (2013)

Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine Models
por: Taniguchi, Makoto, et al.
Publicado: (2020)

Relationship of Leishmania RNA Virus (LRV) and treatment failure in clinical isolates of Leishmania major
por: Abtahi, Mohsen, et al.
Publicado: (2020)

Inositol phosphorylceramide synthase null Leishmania are viable and virulent in animal infections where salvage of host sphingomyelin predominates
por: Kuhlmann, F. Matthew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5h2gch7m8ilfshljj30ol03v8p